Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)Hani Babiker,Erkut Borazanci,Vivek Subbiah,Sanjiv Agarwala,Alain Algazi,Jacob Schachter,Michael Lotem,Corinne Maurice-Dror,Daniel Hendler,Shah Rahimian,Hans Minderman,Cara Haymaker,Daruka Mahadevan,Chantale Bernatchez,Ravi Murthy,Rolf Hultsch,Nadia Kaplan,Gregory Woodhead,Charles Hennemeyer,Srinivas Chunduru,Peter M. Anderson,Adi Diab,Igor Puzanovwos（2023）引用 4|浏览5关键词Toll-like Receptors,Tumor RegressionAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
